EP1011667A4 - Antagonistes de l'hormone de liberation de la gonadotrophine - Google Patents
Antagonistes de l'hormone de liberation de la gonadotrophineInfo
- Publication number
- EP1011667A4 EP1011667A4 EP98926171A EP98926171A EP1011667A4 EP 1011667 A4 EP1011667 A4 EP 1011667A4 EP 98926171 A EP98926171 A EP 98926171A EP 98926171 A EP98926171 A EP 98926171A EP 1011667 A4 EP1011667 A4 EP 1011667A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antagonists
- releasing hormone
- gonadotropin releasing
- gonadotropin
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4863697P | 1997-06-05 | 1997-06-05 | |
US4863797P | 1997-06-05 | 1997-06-05 | |
US48636P | 1997-06-05 | ||
US48637P | 1997-06-05 | ||
GB9719839 | 1997-09-18 | ||
GBGB9719839.4A GB9719839D0 (en) | 1997-09-18 | 1997-09-18 | Antogonists of gonadotropin releasing hormone |
GB9800451 | 1998-01-09 | ||
GBGB9800451.8A GB9800451D0 (en) | 1998-01-09 | 1998-01-09 | Antagonists of gonadotropin releasing hormone |
PCT/US1998/011204 WO1998055119A1 (fr) | 1997-06-05 | 1998-06-01 | Antagonistes de l'hormone de liberation de la gonadotrophine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1011667A1 EP1011667A1 (fr) | 2000-06-28 |
EP1011667A4 true EP1011667A4 (fr) | 2001-03-28 |
Family
ID=27451701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98926171A Withdrawn EP1011667A4 (fr) | 1997-06-05 | 1998-06-01 | Antagonistes de l'hormone de liberation de la gonadotrophine |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1011667A4 (fr) |
JP (1) | JP2002503252A (fr) |
AU (1) | AU7806998A (fr) |
CA (1) | CA2291829A1 (fr) |
WO (1) | WO1998055119A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1197299A (en) * | 1997-10-28 | 1999-05-17 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
WO1999021553A1 (fr) * | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonistes de l'hormone de liberation de la gonadothrophine |
US6346534B1 (en) | 1998-09-23 | 2002-02-12 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
US6537998B1 (en) | 1999-10-15 | 2003-03-25 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
KR100814269B1 (ko) | 2000-01-25 | 2008-03-18 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 고나도트로핀-분비 호르몬 수용체 길항제 및 이를 포함하는 약제학적 조성물 |
GB0022670D0 (en) | 2000-09-15 | 2000-11-01 | Astrazeneca Ab | Molecules |
SE0100566D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
SE0101692D0 (sv) | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
JP2005505525A (ja) | 2001-08-02 | 2005-02-24 | ニューロクライン バイオサイエンシーズ, インコーポレイテッド | 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストおよびそれに関連する方法 |
JP2005500356A (ja) | 2001-08-02 | 2005-01-06 | ニューロクライン バイオサイエンシーズ, インコーポレイテッド | ゴナドトロピン放出ホルモンレセプターアンタゴニスト |
CA2455235A1 (fr) | 2001-08-02 | 2003-02-13 | Joseph Pontillo | 1,2,4-triazin-3,5-diones comme antagonistes du recepteur de l'hormone de liberation des gonadotrophines (gnrh) |
AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
WO2003011293A2 (fr) | 2001-08-02 | 2003-02-13 | Neurocrine Biosciences, Inc. | Antagonistes du recepteur de l'hormone liberant la gonadotropine et procedes associes |
AU2003267551A1 (en) | 2002-08-21 | 2004-03-11 | Astrazeneca Ab | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
AU2003255811A1 (en) | 2002-08-21 | 2004-03-11 | Astrazeneca Ab | Pyrazole derivatives as gnrh inhibitors |
GB0219472D0 (en) | 2002-08-21 | 2002-10-02 | Astrazeneca Ab | Chemical compounds |
TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
ES2314448T3 (es) | 2003-07-07 | 2009-03-16 | Neurocrine Biosciences, Inc. | Derivados de pirimidina-2,4-diona como antagonistas del receptor de la hormona de liberacion de la gonadotropina. |
EP1644342B1 (fr) | 2003-07-07 | 2012-05-09 | Neurocrine Biosciences, Inc. | Arylpyrimidines utiles pour le traitement des états liés aux hormones sexuelles comme l'endométriose, le cancer de prostate et analogues |
WO2005007164A1 (fr) | 2003-07-07 | 2005-01-27 | Neurocrine Biosciences, Inc. | Derives de pyrimidine-2,4-dione, servant d'antagonistes au recepteur de l'hormone de liberation de la gonadotropine |
WO2012175514A1 (fr) | 2011-06-21 | 2012-12-27 | Bayer Intellectual Property Gmbh | Dérivés de pyridinone et compositions pharmaceutiques les contenant |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2240048A1 (fr) * | 1995-12-14 | 1997-06-19 | Mark Goulet | Antagonistes de l'hormone de liberation de la gonadotropine |
-
1998
- 1998-06-01 EP EP98926171A patent/EP1011667A4/fr not_active Withdrawn
- 1998-06-01 AU AU78069/98A patent/AU7806998A/en not_active Abandoned
- 1998-06-01 JP JP50271499A patent/JP2002503252A/ja active Pending
- 1998-06-01 WO PCT/US1998/011204 patent/WO1998055119A1/fr not_active Application Discontinuation
- 1998-06-01 CA CA002291829A patent/CA2291829A1/fr not_active Abandoned
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO9855119A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1011667A1 (fr) | 2000-06-28 |
CA2291829A1 (fr) | 1998-12-10 |
WO1998055119A1 (fr) | 1998-12-10 |
AU7806998A (en) | 1998-12-21 |
JP2002503252A (ja) | 2002-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0986385A4 (fr) | Antagonistes de gonadoliberine | |
EP0986557A4 (fr) | Antagonistes de la gonadoliberine | |
IL124554A0 (en) | Antagonists of gonadotropin releasing hormone | |
IL124613A0 (en) | Antagonists of gonadotropin releasing hormone | |
EP0868178A4 (fr) | Antagonistes de la gonadoliberine | |
EP0918522A4 (fr) | Antagonistes de la gonadoliberine | |
AU3008997A (en) | Antagonists of gonadotropin releasing hormone | |
ZA9610535B (en) | Antagonists of gonadotropin releasing hormone. | |
ZA9610536B (en) | Antagonists of gonadotropin releasing hormone. | |
EP1011667A4 (fr) | Antagonistes de l'hormone de liberation de la gonadotrophine | |
EP1067930A4 (fr) | Antagonistes de l'hormone liberant la gonadotropine (gnrh) | |
EP1027046A4 (fr) | Antagonistes de l'hormone de liberation de la gonadothrophine | |
EP0901471A4 (fr) | Antagonistes de la gonadoliberine | |
EP0920319A4 (fr) | Antagonistes de la gonadoliberine | |
EP1049472A4 (fr) | Antagonistes de la gonadoliberine | |
AU4834900A (en) | Antagonists of gonadotropin releasing hormone | |
EP1062215A4 (fr) | Antagonistes de l'hormone de liberation de la gonadotrophine | |
GB9719840D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9719386D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9719387D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9719391D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9603242D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9612084D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9603344D0 (en) | Antagonists of gonadotropin releasing hormone | |
GB9603369D0 (en) | Antagonists of gonadotropin releasing hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000105 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/41 A, 7A 61K 31/44 B, 7C 07D 249/08 B, 7C 07D 257/04 B, 7C 07D 271/06 B, 7C 07D 401/14 B, 7C 07D 403/12 B, 7C 07D 413/12 B, 7C 07D 521/00 B, 7C 07D 487/08 B, 7C 07D 401/12 B, 7C 07D 471/08 B, 7A 61K 38/09 B, 7A 61P 5/02 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010212 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20010503 |